<DOC>
	<DOCNO>NCT00336609</DOCNO>
	<brief_summary>Observational ( non-drug ) study look risk burden mucositis ( sore ) involve mouth , throat intestine patient receive chemotherapy radiation therapy treatment various cancer type .</brief_summary>
	<brief_title>TRIAD Burden Illness Mucositis Study</brief_title>
	<detailed_description>This comprehensive , observational study prospectively elicit true incidence ( risk ) health economic burden mucosal toxicity associate anti-cancer drug radiation therapy . This study examine burden illness gastrointestinal mucositis ( define mucositis involve mouth , esophagus , small intestine ) significant regimen use treat common type cancer . It international investigation 1600 patient treat specific regimens cancer head neck , breast , colon , lung ( NSCLC ) Non-Hogkin 's Lymphoma prospectively enrol center throughout US , Canada , Europe Australia .</detailed_description>
	<mesh_term>Mucositis</mesh_term>
	<criteria>18 year old Ability understand protocol willing provide write informed consent Membership one follow subcohorts : 1 . Histologically proven oral cavity oropharyngeal cancer plan receive full cycle daily single fraction radiation therapy ( without boost ) IMRT +/ chemotherapy . 2 . Histologically proven laryngeal hypopharyngeal cancer plan receive full cycle daily single fraction radiation ( without boost ) +/ chemotherapy . 3 . Histologically proven adenocarcinoma colon rectum plan receive minimum 2 cycle FOLFOX +/ Avastin Erbitux.1 cycle define 2 dos FOLFOX . 4 . Histologically proven adenocarcinoma colon rectum plan receive minimum 2 cycle FOLFIRI +/ Avastin Erbitux . 1 cycle define 2 dos FOLFIRI . 5 . Adenocarcinoma breast plan receive minimum 2 cycle TAC . 6 . Histologically proven adenocarcinoma ( primary ) plan receive minimum 2 cycle capecitabine . 7 . Adenocarcinoma breast plan receive standard dosedense doxorubicin cyclophosphamide ( AC ) follow paclitaxel ( T ) ( 4 cycle AC follow 2 cycle T ) . 8 . Stage 3A 3B nonsmall cell lung cancer plan receive daily single fraction radiation without boost ( 1 fraction daily 56 week ) +/ Carbo/Taxol . 9 . Bcell NonHodgkin â€™ lymphoma ( NHL ) plan receive least 2 cycle CHOP14 , CHOEP14 , CHOPDI14 , EPOCH14 CHOP21 +/ rituxan</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2007</verification_date>
</DOC>